>…you can bet that Crapaxone will be cannibalized further and can achieve growth only through price increases<
Ridiculing a drug that is doing $1.5B a year in global sales and is number one in its category may win you some points on the ELN board on iVillage, but not here.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”